ARQT Arcutis Biotherapeutics, Inc. - Common stock
$27.03
价格 · 八月 19, 2026
截至...的财报数据 八月 5, 2026
52周区间
$15–$32
72% of range
分析师评级
BUY
14 analysts
目标价
$37
+36% upside
P/E (TTM)
-207.9
ROE
-9.8%
净利润率
-4.3%
ARQT 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$27.03
市值
$3.33B
P/E (TTM)
-207.9
每股收益 (TTM)
$-0.13
营收 (TTM)
$376M
股息收益率
—
ROE
-9.8%
负债/权益
0.6
52周区间
$15 – $32
ARQT 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$376M
2020-12-31
→
2025-12-31
EPS
$-0.13
2019-12-31
→
2025-12-31
自由现金流
$-6M
2020-12-31
→
2025-12-31
利润率
-4.3%
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
ARQT
同行中位数
P/E (TTM)
-207.9
—
P/S (TTM) (市销率 (TTM))
8.9
18.3
P/B (市净率)
17.6
3.3
EV / EBITDA (企业价值 / EBITDA)
-278.1
—
Price / FCF (股价/自由现金流)
-528.2
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
ARQT
同行中位数
Operating Margin (营业利润率)
-3.2%
—
Net Profit Margin (净利润率)
-4.3%
-180.4%
ROA
-4.1%
-36.2%
ROE
-9.8%
-43.7%
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
ARQT
同行中位数
Debt / Equity (负债/股东权益比率)
0.6
—
Current Ratio (流动比率)
3.2
9.7
Quick Ratio (速动比率)
1.5
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
ARQT
同行中位数
Revenue YoY (营收同比增长)
91.3%
—
Revenue CAGR 3Y (营收3年复合年增长率)
367.3%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
ARQT
同行中位数
ARQT 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
14 位分析师
- 强烈买入 4 28.6%
- 买入 8 57.1%
- 持有 2 14.3%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
8 位分析师 · 2026-08-13
中位数
$37.00
← 低于所有目标
$27.03
最低
$34.00
最高
$40.00
中位数目标
$37.00
+36.9%
平均目标
$36.88
+36.4%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
0.05%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $0.11 | $0.04 | 0.07% |
| 2026年3月31日 | $-0.09 | $-0.08 | -0.01% |
| 2025年12月31日 | $0.13 | $0.12 | 0.01% |
| 2025年9月30日 | $0.06 | $-0.10 | 0.16% |
| 2025年6月30日 | $-0.13 | $-0.16 | 0.03% |
| 2025年3月31日 | $-0.20 | $-0.21 | 0.01% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | — |
| RCUS | $2.99B | -7.2 | -4.3% | -142.9% | -59.8% | — |
| VCYT | $3.34B | 51.3 | 16.0% | 12.8% | 5.2% | 70.1% |
| IDYA | $3.04B | -27.0 | 3024.4% | -52.0% | -11.5% | — |
| CLDX | $1.81B | -7.0 | -78.0% | -16748.0% | -43.8% | — |
| GRAL | $3.45B | -7.7 | 17.2% | -277.5% | -16.7% | — |
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | — |
| IMNM | $2.43B | -8.8 | -23.2% | -3060.0% | -47.0% | — |
| IRON | $3.01B | -13.2 | — | — | -31.3% | — |
| NRIX | $1.80B | -5.8 | 53.9% | -314.9% | -53.6% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 15
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $376M | $197M | $60M | $4M | $0 | $0 | |
| Cost of Revenue | $37M | $19M | $5M | $754.0K | $0 | · | |
| R&D Expense | $77M | $76M | $111M | $182M | $146M | $115M | |
| SG&A Expense | $275M | $229M | $185M | $122M | $61M | $21M | |
| Operating Expenses | $388M | $325M | $301M | $305M | $207M | $137M | |
| Operating Income | $-12M | $-128M | $-241M | $-302M | $-207M | $-137M | |
| Interest Expense | · | · | $30M | $16M | $0 | $0 | |
| Other Non-op | $443.0K | $47.0K | $-731.0K | $6M | $173.0K | $967.0K | |
| Income Tax | $1M | $647.0K | $3M | $0 | $0 | $0 | |
| Net Income | $-16M | $-140M | $-262M | $-311M | $-206M | $-136M | |
| EPS (Basic) | $-0.13 | $-1.16 | $-3.78 | $-5.66 | $-4.18 | $-3.80 | |
| EPS (Diluted) | $-0.13 | $-1.16 | $-3.78 | $-5.66 | $-4.18 | $-3.80 | |
| Shares (Basic) | 127,234,000 | 120,958,000 | 69,305,000 | 55,032,265 | 49,405,575 | 35,668,152 | |
| Shares (Diluted) | 127,234,000 | 120,958,000 | 69,305,000 | 55,032,265 | 49,405,575 | 35,668,152 | |
| EBITDA | $-12M | $-128M | $-241M | · | · | $-137M |
资产负债表 26
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $71M | $88M | $54M | $96M | $65M | |
| Receivables | $146M | $73M | $26M | $8M | $0 | · | |
| Inventory | $23M | $15M | $13M | $8M | $0 | · | |
| Prepaid Expense | $21M | $20M | $19M | $11M | $14M | $7M | |
| Current Assets | $411M | $336M | $330M | $437M | $403M | $293M | |
| PP&E (Net) | $1M | $1M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | $4M | $4M | $3M | $3M | $3M | $2M | |
| Accum. Depreciation | $3M | $3M | $2M | $1M | $532.0K | $78.0K | |
| Intangibles | $15M | $9M | $6M | $7M | $0 | · | |
| Other Non-current Assets | $1M | $596.0K | $596.0K | $78.0K | $78.0K | $78.0K | |
| Total Assets | $433M | $349M | $341M | $449M | $408M | $298M | |
| Accounts Payable | $13M | $14M | $12M | $9M | $7M | $7M | |
| Accrued Liabilities | $116M | $67M | $34M | $28M | $26M | $15M | |
| Current Liabilities | $130M | $81M | $47M | $38M | $33M | $23M | |
| Capital Leases | $5M | $3M | $3M | $4M | $5M | $5M | |
| Other Non-current Liabilities | $431.0K | $570.0K | $849.0K | $0 | $25.0K | $82.0K | |
| Total Liabilities | $243M | $191M | $253M | $240M | $110M | $28M | |
| Long-term Debt | $109M | $107M | $202M | $198M | $72M | $0 | |
| Total Debt | $109M | $107M | $202M | · | · | · | |
| Common Stock | $12.0K | $12.0K | $9.0K | $6.0K | $5.0K | $4.0K | |
| Paid-in Capital | $1.33B | $1.28B | $1.07B | $930M | $706M | $473M | |
| Retained Earnings | $-1.14B | $-1.12B | $-982M | $-720M | $-408M | $-202M | |
| AOCI | $-44.0K | $-7.0K | $4.0K | $-1M | $-255.0K | $-2.0K | |
| Stockholders' Equity | $189M | $158M | $89M | $210M | $298M | $271M | |
| Liabilities + Equity | $433M | $349M | $341M | $449M | $408M | $298M | |
| Shares Outstanding | 123,333,000 | 117,848,033 | 96,787,343 | 61,037,403 | 50,255,614 | 43,338,438 |
现金流 14
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $40M | $42M | $39M | $33M | $24M | $8M | |
| Deferred Tax | $54.0K | $-152.0K | $0 | $0 | $0 | · | |
| Amort. of Intangibles | $5M | $2M | $750.0K | $312.0K | $0 | $0 | |
| Operating Cash Flow | $-6M | $-112M | $-247M | $-258M | $-175M | $-113M | |
| CapEx | $686.0K | $143.0K | $428.0K | $333.0K | $995.0K | $321.0K | |
| Investing Cash Flow | $-30M | $29M | $180M | $-87M | $-76M | $-182M | |
| Debt Issued | · | $0 | $0 | $125M | $74M | $0 | |
| Net Debt Issued | $0 | $-100M | $0 | · | · | · | |
| Stock Issued | $0 | $162M | $0 | $162M | $207M | $128M | |
| Net Stock Activity | $0 | $162M | $0 | · | · | $128M | |
| Financing Cash Flow | $7M | $66M | $101M | $302M | $282M | $298M | |
| Net Change in Cash | $-29M | $-17M | $34M | $-43M | $31M | $3M | |
| Taxes Paid | $0 | $0 | $0 | · | · | · | |
| Free Cash Flow | $-6M | $-112M | $-247M | · | · | $-113M |
盈利能力 5
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -3.2% | -65.3% | -404.5% | · | · | · | |
| Net Margin | -4.3% | -71.2% | -439.8% | · | · | · | |
| EBITDA Margin | -3.2% | -65.3% | -404.5% | · | · | · | |
| ROA | -4.1% | -40.6% | -66.3% | · | · | -67.0% | |
| ROE | -9.8% | -89.1% | -387.2% | · | · | -61.2% |
流动性与偿付能力 5
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | 4.1 | 7.1 | · | · | 13.0 | |
| Quick Ratio | 1.5 | 1.8 | 2.4 | · | · | 2.9 | |
| Debt / Equity | 0.6 | 0.7 | 2.3 | · | · | · | |
| LT Debt / Equity | 0.6 | 0.7 | 2.3 | · | · | · | |
| Interest Coverage | · | · | -8.1 | · | · | · |
效率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 0.6 | 0.2 | · | · | · | |
| Inventory Turnover | 2.0 | 1.4 | 0.5 | · | · | · | |
| Receivables Turnover | 3.4 | 4.0 | 3.5 | · | · | · |
增长率 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 91.3% | 229.7% | 1517.1% | · | · | · | |
| Revenue CAGR 3Y | 367.3% | · | · | · | · | · |
估值 (TTM) 14
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $376M | $197M | $60M | $4M | $0 | $0 | |
| Net Income TTM | $-16M | $-140M | $-262M | $-311M | $-206M | $-136M | |
| Market Cap | $3.58B | $1.64B | $313M | · | · | $1.22B | |
| Enterprise Value | $3.65B | $1.68B | $426M | · | · | · | |
| P/E | -223.4 | -12.0 | -0.9 | -2.6 | -5.0 | -7.4 | |
| P/S | 9.5 | 8.4 | 5.2 | · | · | · | |
| P/B | 18.9 | 10.4 | 3.5 | · | · | 4.5 | |
| P / Tangible Book | 20.5 | 11.1 | 3.8 | 4.5 | 3.5 | 4.5 | |
| P / Cash Flow | -636.7 | -14.6 | -1.3 | · | · | -10.8 | |
| P / FCF | -567.5 | -14.6 | -1.3 | · | · | -10.8 | |
| EV / EBITDA | -298.3 | -13.1 | -1.8 | · | · | · | |
| EV / FCF | -578.0 | -14.9 | -1.7 | · | · | · | |
| EV / Revenue | 9.7 | 8.5 | 7.1 | · | · | · | |
| Earnings Yield | -0.45% | -8.3% | -117.0% | -38.2% | -20.2% | -13.5% |
损益表 16
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $130M | $105M | $130M | $99M | $82M | $66M | $71M | $45M | $31M | $50M | $14M | $38M | $5M | $3M | $3M | $725.0K | |
| Cost of Revenue | $11M | $10M | $12M | $9M | $7M | $9M | $7M | $6M | $3M | $3M | $2M | $1M | $776.0K | $783.0K | · | · | |
| R&D Expense | $20M | $31M | $20M | $20M | $19M | $18M | $14M | $20M | $19M | $23M | $24M | $26M | $25M | $35M | $34M | $70M | |
| SG&A Expense | $82M | $74M | $79M | $62M | $69M | $64M | $58M | $59M | $58M | $55M | $49M | $48M | $46M | $43M | $37M | $35M | |
| Operating Expenses | $113M | $114M | $111M | $91M | $96M | $90M | $79M | $84M | $81M | $81M | $75M | $75M | $72M | $79M | $71M | $105M | |
| Operating Income | $16M | $-9M | $18M | $9M | $-15M | $-25M | $-8M | $-39M | $-50M | $-32M | $-61M | $-37M | $-67M | $-76M | $-68M | $-105M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $7M | · | $8M | $7M | $7M | · | $5M | |
| Interest Income | $2M | · | · | · | $2M | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $-157.0K | $-20.0K | $-6M | $2M | $20.0K | $193.0K | $-13M | $4M | $5M | $4M | $-10M | $3M | $3M | $3M | $3M | $2M | |
| Income Tax | $136.0K | $93.0K | $470.0K | $80.0K | $342.0K | $279.0K | $323.0K | $0 | $0 | $324.0K | $90.0K | $3M | $0 | $0 | $0 | $0 | |
| Net Income | $15M | $-11M | $17M | $7M | $-16M | $-25M | $-11M | $-42M | $-52M | $-35M | $-66M | $-45M | $-71M | $-80M | $-72M | $-108M | |
| EPS (Basic) | $0.11 | $-0.09 | $0.14 | $0.06 | $-0.13 | $-0.20 | $-0.09 | $-0.33 | $-0.42 | $-0.32 | $-0.58 | $-0.73 | $-1.16 | $-1.31 | $-1.19 | $-1.89 | |
| EPS (Diluted) | $0.11 | $-0.09 | $0.14 | $0.06 | $-0.13 | $-0.20 | $-0.09 | $-0.33 | $-0.42 | $-0.32 | $-0.58 | $-0.73 | $-1.16 | $-1.31 | $-1.19 | $-1.89 | |
| Shares (Basic) | 130,522,000 | 129,365 | -253,422,862 | 127,623,000 | 126,997,000 | 126,037 | -237,873,525 | 124,302,000 | 123,481,000 | 111,048,525 | -115,021,987 | 61,727,278 | 61,430,620 | 61,169,089 | -103,995,388 | 57,091,743 | |
| Shares (Diluted) | 135,898,000 | 129,365 | -258,684,862 | 132,885,000 | 126,997,000 | 126,037 | -237,873,525 | 124,302,000 | 123,481,000 | 111,048,525 | -115,021,987 | 61,727,278 | 61,430,620 | 61,169,089 | -103,995,388 | 57,091,743 | |
| EBITDA | $16M | $-9M | · | $9M | $-15M | $-25M | · | $-39M | $-50M | · | · | $-37M | · | · | · | $-105M |
资产负债表 26
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $34M | $35M | $43M | $47M | $73M | $53M | $71M | $135M | $84M | $190M | · | $107M | $105M | $81M | · | $82M | |
| Receivables | $155M | $144M | $146M | $115M | $107M | $85M | $73M | $60M | $43M | $37M | · | $19M | $17M | $13M | · | $2M | |
| Inventory | $39M | $37M | $23M | $22M | $16M | $17M | $15M | $14M | $14M | $13M | · | $14M | $10M | $9M | · | $4M | |
| Prepaid Expense | $35M | $32M | $21M | $20M | $19M | $23M | $20M | $18M | $14M | $13M | · | $20M | $12M | $13M | · | $12M | |
| Current Assets | $468M | $438M | $411M | $349M | $333M | $324M | $336M | $424M | $435M | $468M | · | $282M | $309M | $368M | · | $497M | |
| PP&E (Net) | $872.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | $2M | $2M | $2M | · | $2M | |
| PP&E (Gross) | · | · | $4M | · | · | · | $4M | · | · | · | · | $3M | $3M | $3M | · | $3M | |
| Accum. Depreciation | · | · | $3M | · | · | · | $3M | · | · | · | · | $2M | $2M | $1M | · | $993.0K | |
| Intangibles | $14M | $14M | $15M | $15M | $16M | $16M | $9M | $10M | $6M | $6M | · | $7M | $7M | $7M | · | $7M | |
| Other Non-current Assets | $2M | $2M | $1M | $596.0K | $596.0K | $596.0K | $596.0K | $596.0K | $595.0K | $596.0K | · | $596.0K | $596.0K | $78.0K | · | $78.0K | |
| Total Assets | $489M | $460M | $433M | $371M | $352M | $344M | $349M | $437M | $445M | $479M | · | $293M | $321M | $379M | · | $509M | |
| Accounts Payable | $7M | $18M | $13M | $6M | $15M | $25M | $14M | $19M | $8M | $13M | · | $13M | $17M | $12M | · | $9M | |
| Accrued Liabilities | $147M | $137M | $116M | $93M | $88M | $66M | $67M | $53M | $43M | $34M | · | $28M | $19M | $24M | · | $28M | |
| Current Liabilities | $160M | $163M | $130M | $100M | $104M | $91M | $81M | $172M | $51M | $47M | · | $42M | $37M | $37M | · | $37M | |
| Capital Leases | $5M | $5M | $5M | $5M | $2M | $2M | $3M | $3M | $3M | $3M | · | $4M | $4M | $4M | · | $4M | |
| Other Non-current Liabilities | $431.0K | $431.0K | $431.0K | $360.0K | $360.0K | $360.0K | $570.0K | $420.0K | $194.0K | $306.0K | · | · | · | · | · | $0 | |
| Total Liabilities | $268M | $270M | $243M | $213M | $213M | $201M | $191M | $281M | $258M | $254M | · | $246M | $240M | $240M | · | $238M | |
| Long-term Debt | $109M | $109M | $109M | $108M | $108M | $108M | $107M | $205M | $204M | $203M | · | $201M | $200M | $199M | · | $197M | |
| Total Debt | $109M | $109M | · | $108M | $108M | $108M | · | $205M | $204M | · | · | $201M | · | · | · | $197M | |
| Common Stock | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | · | $6.0K | $6.0K | $6.0K | · | $6.0K | |
| Paid-in Capital | $1.36B | $1.34B | $1.33B | $1.31B | $1.30B | $1.29B | $1.28B | $1.27B | $1.26B | $1.24B | · | $963M | $952M | $940M | · | $920M | |
| Retained Earnings | $-1.13B | $-1.15B | $-1.14B | $-1.16B | $-1.16B | $-1.15B | $-1.12B | $-1.11B | $-1.07B | $-1.02B | · | $-916M | $-871M | $-800M | · | $-648M | |
| AOCI | $-656.0K | $-514.0K | $-44.0K | $-62.0K | $-35.0K | $-140.0K | $-7.0K | $533.0K | $-294.0K | $-133.0K | · | $-184.0K | $-292.0K | $-414.0K | · | $-2M | |
| Stockholders' Equity | $221M | $190M | $189M | $158M | $139M | $143M | $158M | $157M | $186M | $225M | $89M | $47M | $81M | $140M | $210M | $271M | |
| Liabilities + Equity | $489M | $460M | $433M | $371M | $352M | $344M | $349M | $437M | $445M | $479M | · | $293M | $321M | $379M | · | $509M | |
| Shares Outstanding | 125,591,000 | 125,042,000 | 123,332,672 | 120,288,146 | 119,797,738 | 119,137,785 | 117,848,033 | 116,998,829 | 116,480,267 | 115,505,437 | · | 61,858,044 | 61,630,018 | 61,357,932 | · | 60,908,641 |
现金流 11
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $13M | $11M | $10M | $10M | $10M | $10M | $9M | $10M | $13M | $10M | $9M | $10M | $11M | $9M | $9M | $9M | |
| Amort. of Intangibles | $563.0K | $562.0K | $563.0K | $562.0K | $563.0K | $3M | $313.0K | $1M | $200.0K | $188.0K | $-188M | $188M | $200.0K | $188.0K | $187.0K | $125.0K | |
| Operating Cash Flow | $13M | $2M | $26M | $-2M | $324.0K | $-30M | $-748.0K | $-35M | $-45M | $-32M | $-56M | $-44M | $-66M | $-80M | $-71M | $-68M | |
| CapEx | $158.0K | $0 | $0 | $0 | $78.0K | $608.0K | $0 | $143.0K | $0 | $0 | $6.0K | $64.0K | $276.0K | $82.0K | $123.0K | $6.0K | |
| Investing Cash Flow | $-15M | $-11M | $-34M | $-25M | $17M | $12M | $35M | $85M | $-62M | $-29M | $-62M | $46M | $89M | $108M | $42M | $-197M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Stock Issued | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $162M | $0 | $0 | $0 | $0 | $0 | $162M | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $2M | $1M | $4M | $1M | $1M | $395.0K | $-97M | $394.0K | $1M | $162M | $99M | $867.0K | $1M | $100.0K | $962.0K | $285M | |
| Net Change in Cash | $-641.0K | $-8M | $-4M | $-26M | $19M | $-18M | $-64M | $51M | $-106M | $101M | $-19M | $2M | $24M | $27M | $-28M | $20M | |
| Free Cash Flow | · | $2M | · | · | · | $-31M | · | · | · | · | · | · | · | · | · | · |
盈利能力 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 12.7% | -8.6% | · | 8.6% | -17.9% | -37.2% | · | -87.3% | -162.3% | · | · | -96.8% | · | · | · | -14448.0% | |
| Net Margin | 11.6% | -10.7% | · | 7.5% | -19.5% | -38.1% | · | -92.8% | -169.6% | · | · | -117.5% | · | · | · | -14856.4% | |
| EBITDA Margin | 12.7% | -8.6% | · | 8.6% | -17.9% | -37.2% | · | -87.3% | -162.3% | · | · | -96.8% | · | · | · | -14448.0% | |
| ROA | 3.6% | -2.8% | · | 1.8% | -4.0% | -6.1% | · | -11.4% | -13.7% | · | · | -11.2% | · | · | · | -24.0% | |
| ROE | 8.3% | -6.8% | · | 4.7% | -9.8% | -13.6% | · | -40.8% | -39.2% | · | · | -28.2% | · | · | · | -34.0% |
流动性与偿付能力 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.9 | 2.7 | · | 3.5 | 3.2 | 3.6 | · | 2.5 | 8.5 | · | · | 6.7 | · | · | · | 13.4 | |
| Quick Ratio | 1.2 | 1.1 | · | 1.6 | 1.7 | 1.5 | · | 1.1 | 2.5 | · | · | 3.0 | · | · | · | 2.3 | |
| Debt / Equity | 0.5 | 0.6 | · | 0.7 | 0.8 | 0.8 | · | 1.3 | 1.1 | · | · | 4.3 | · | · | · | 0.7 | |
| LT Debt / Equity | 0.5 | 0.5 | · | 0.7 | 0.8 | 0.8 | · | 0.7 | 1.1 | · | · | 4.3 | · | · | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | -4.9 | · | · | · | -21.4 |
效率 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.1 | · | · | 0.1 | · | · | · | 0.0 | |
| Inventory Turnover | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.6 | · | 0.4 | 0.3 | · | · | · | · | · | · | · | |
| Receivables Turnover | 1.0 | 0.9 | · | 1.1 | 1.1 | 1.1 | · | 1.1 | 1.0 | · | · | 3.5 | · | · | · | 0.6 |
估值 (TTM) 14
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $416M | $352M | · | $291M | $223M | $191M | · | $163M | $124M | $96M | · | $47M | $9M | $4M | · | $725.0K | |
| Net Income TTM | $-5M | $-45M | · | $-75M | $-135M | $-154M | · | $-174M | $-203M | $-231M | · | $-304M | $-326M | $-320M | · | $-296M | |
| Market Cap | $3.29B | $2.95B | · | $2.27B | $1.68B | $1.86B | · | $1.09B | $1.08B | · | · | $328M | · | · | · | $1.16B | |
| Enterprise Value | $3.37B | $3.02B | · | $2.33B | $1.71B | $1.92B | · | $1.16B | $1.20B | · | · | $422M | · | · | · | $1.28B | |
| P/E | -524.4 | -65.4 | · | -31.4 | -13.0 | -12.3 | · | -5.2 | -3.5 | -2.8 | · | -1.0 | -1.7 | -1.9 | · | -3.4 | |
| P/S | 7.9 | 8.4 | · | 7.8 | 7.5 | 9.8 | · | 6.7 | 8.8 | · | · | 7.0 | · | · | · | 1605.5 | |
| P/B | 14.9 | 15.5 | · | 14.3 | 12.1 | 13.1 | · | 6.9 | 5.8 | · | · | 7.0 | · | · | · | 4.3 | |
| P / Tangible Book | 15.9 | 16.8 | · | 15.9 | 13.7 | 14.8 | · | 7.4 | 6.0 | 5.2 | · | 8.2 | 8.0 | 5.1 | · | 4.4 | |
| P / Cash Flow | · | 1315.8 | · | · | · | -61.3 | · | · | · | · | · | · | · | · | · | · | |
| P / FCF | · | 1315.8 | · | · | · | -60.1 | · | · | · | · | · | · | · | · | · | · | |
| EV / EBITDA | 205.0 | -332.3 | · | 273.1 | -117.4 | -78.2 | · | -29.6 | -24.0 | · | · | -11.4 | · | · | · | -12.2 | |
| EV / FCF | · | 1349.1 | · | · | · | -61.9 | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 8.1 | 8.6 | · | 8.0 | 7.7 | 10.0 | · | 7.1 | 9.7 | · | · | 9.0 | · | · | · | 1764.4 | |
| Earnings Yield | -0.19% | -1.5% | · | -3.2% | -7.7% | -8.1% | · | -19.4% | -28.3% | -35.5% | · | -95.9% | -59.5% | -52.5% | · | -29.4% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $376M | $197M | $60M | $4M | $0 |
| 营业利润率 % | -3.2% | -65.3% | -404.5% | — | — |
| 净收入 | $-16M | $-140M | $-262M | $-311M | $-206M |
| 稀释后每股收益 (EPS) | $-0.13 | $-1.16 | $-3.78 | $-5.66 | $-4.18 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 0.6 | 0.7 | 2.3 | — | — |
| 流动比率 | 3.2 | 4.1 | 7.1 | — | — |
| 速动比率 | 1.5 | 1.8 | 2.4 | — | — |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $-6M | $-112M | $-247M | — | — |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 292 家申报者 · $2.6B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 47 (+10 与上一季度对比) | 33 (-9 与上一季度对比) | 90 (-8 与上一季度对比) | 96 (+4 与上一季度对比) | +5.9M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $326098140 | 12437000 | 12.35% | 股份 |
| Frazier Life Sciences Management, L.P. | $258909678 | 9874511 | 9.80% | 股份 |
| Rubric Capital Management LP | $216880749 | 8271577 | 8.21% | 股份 |
| Polar Capital Holdings Plc | $173234098 | 6606945 | 6.56% | 股份 |
| STATE STREET CORP | $152674865 | 5822840 | 5.78% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $130805182 | 4988756 | 4.95% | 股份 |
| JENNISON ASSOCIATES LLC | $86505943 | 3299235 | 3.28% | 股份 |
| D. E. Shaw & Co., Inc. | $81220383 | 3097650 | 3.08% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $67179379 | 2561595 | 2.54% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $63688511 | 2429005 | 2.41% | 股份 |
| ORBIMED ADVISORS LLC | $53541240 | 2042000 | 2.03% | 股份 |
| AMERICAN CENTURY COMPANIES INC | $50474363 | 1925031 | 1.91% | 股份 |
| JANUS HENDERSON GROUP PLC | $42621972 | 1809466 | 1.61% | 股份 |
| OBERWEIS ASSET MANAGEMENT INC/ | $35998513 | 1372941 | 1.36% | 股份 |
| GILDER GAGNON HOWE & CO LLC | $34432392 | 1313211 | 1.30% | 股份 |
| Pivotal bioVenture Partners Investment Advisor LLC | $33175720 | 1265283 | 1.26% | 股份 |
| BANK OF AMERICA CORP /DE/ | $33121130 | 1263201 | 1.25% | 股份 |
| BAMCO INC /NY/ | $32856806 | 1253120 | 1.24% | 股份 |
| CITADEL ADVISORS LLC | $29766543 | 1135261 | 1.13% | 股份 |
| Aberdeen Group plc | $28635465 | 1092123 | 1.08% | 股份 |
| Jones Hill Capital LP | $28571960 | 1089701 | 1.08% | 股份 |
| GOLDMAN SACHS GROUP INC | $28558011 | 1089169 | 1.08% | 股份 |
| Perpetual Ltd | $27642802 | 1054264 | 1.05% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $27555489 | 1050934 | 1.04% | 股份 |
| Ensign Peak Advisors, Inc | $25552281 | 974534 | 0.97% | 股份 |
| Candriam S.C.A. | $24880817 | 949839 | 0.94% | 股份 |
| Driehaus Capital Management LLC | $23032330 | 878426 | 0.87% | 股份 |
| VANGUARD GROUP INC | $22159001 | 763051 | 0.84% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $21372918 | 815138 | 0.81% | 股份 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $21284137 | 811752 | 0.81% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $17406855 | 663877 | 0.66% | 股份 |
| FISHMAN JAY A LTD/MI | $15601031 | 595005 | 0.59% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $14789968 | 564072 | 0.56% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $14349629 | 547278 | 0.54% | 股份 |
| Squarepoint Ops LLC | $14099726 | 537747 | 0.53% | 股份 |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | $13110000 | 500000 | 0.50% | 股份 |
| Nearwater Capital Markets, Ltd | $12761274 | 486700 | 0.48% | 股份 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $12218520 | 466000 | 0.46% | 股份 |
| Privium Fund Management B.V. | $10471403 | 399367 | 0.40% | 股份 |
| NORGES BANK | $10286106 | 392300 | 0.39% | 股份 |
| Patient Square Capital LP | $9701400 | 370000 | 0.37% | 股份 |
| Point72 Asset Management, L.P. | $9503413 | 362449 | 0.36% | 股份 |
| Qube Research & Technologies Ltd | $9482778 | 361662 | 0.36% | 股份 |
| Longaeva Partners L.P. | $9040551 | 344796 | 0.34% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $8741748 | 333400 | 0.33% | 买入期权 |
| FMR LLC | $8001453 | 305166 | 0.30% | 股份 |
| PEREGRINE CAPITAL MANAGEMENT LLC | $7641740 | 291447 | 0.29% | 股份 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $7467168 | 284789 | 0.28% | 股份 |
| FIRST TRUST ADVISORS LP | $7448184 | 284065 | 0.28% | 股份 |
| AMERIPRISE FINANCIAL INC | $7133676 | 272070 | 0.27% | 股份 |
| Walleye Capital LLC | $6818065 | 260033 | 0.26% | 股份 |
| Balyasny Asset Management L.P. | $6374580 | 243119 | 0.24% | 股份 |
| PFM Health Sciences, LP | $6347049 | 242069 | 0.24% | 股份 |
| MYDA Advisors LLC | $6292800 | 240000 | 0.24% | 股份 |
| STATE OF WISCONSIN INVESTMENT BOARD | $6054329 | 230905 | 0.23% | 股份 |
| Swiss National Bank | $5873280 | 224000 | 0.22% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5763549 | 219815 | 0.22% | 股份 |
| Pictet Asset Management Holding SA | $5350188 | 200275 | 0.20% | 股份 |
| KORNITZER CAPITAL MANAGEMENT INC /KS | $5235688 | 199683 | 0.20% | 股份 |
| Woodline Partners LP | $5113765 | 195033 | 0.19% | 股份 |
| BlackRock, Inc. | $4724084 | 180171 | 0.18% | 股份 |
| Cormorant Asset Management, LP | $4588500 | 175000 | 0.17% | 股份 |
| PRINCIPAL FINANCIAL GROUP INC | $4586166 | 174911 | 0.17% | 股份 |
| TWO SIGMA ADVISERS, LP | $4533144 | 156100 | 0.17% | 股份 |
| RHUMBLINE ADVISERS | $4471596 | 170542 | 0.17% | 股份 |
| Holocene Advisors, LP | $4293053 | 163732 | 0.16% | 股份 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $4127788 | 157429 | 0.16% | 股份 |
| PDT Partners, LLC | $4066067 | 155075 | 0.15% | 股份 |
| CITIGROUP INC | $3796394 | 144790 | 0.14% | 股份 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $3616499 | 137929 | 0.14% | 股份 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $3605250 | 137500 | 0.14% | 股份 |
| CASTLEARK MANAGEMENT LLC | $3603152 | 137420 | 0.14% | 股份 |
| Eversept Partners, LP | $3549008 | 135355 | 0.13% | 股份 |
| LAZARD ASSET MANAGEMENT LLC | $3491088 | 133146 | 0.13% | 股份 |
| TUDOR INVESTMENT CORP ET AL | $3458785 | 131914 | 0.13% | 股份 |
| MORGAN STANLEY | $3424175 | 130594 | 0.13% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $3213419 | 136393 | 0.12% | 股份 |
| JANE STREET GROUP, LLC | $3088716 | 117800 | 0.12% | 买入期权 |
| 1492 Capital Management LLC | $3047052 | 116211 | 0.12% | 股份 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $3023149 | 128317 | 0.11% | 股份 |
| Tejara Capital Ltd | $2965062 | 113084 | 0.11% | 股份 |
| LPL Financial LLC | $2914353 | 111150 | 0.11% | 股份 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $2776671 | 103762 | 0.11% | 股份 |
| STEMPOINT CAPITAL LP | $2594338 | 98945 | 0.10% | 股份 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $2496000 | 95197 | 0.09% | 股份 |
| CITADEL ADVISORS LLC | $2480412 | 94600 | 0.09% | 买入期权 |
| Aquatic Capital Management LLC | $2258329 | 86130 | 0.09% | 股份 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $2255628 | 86027 | 0.09% | 股份 |
| VANGUARD ASSET MANAGEMENT, Ltd | $2135488 | 81445 | 0.08% | 股份 |
| WESBANCO BANK INC | $2126442 | 81100 | 0.08% | 股份 |
| Rafferty Asset Management, LLC | $2117973 | 80777 | 0.08% | 股份 |
| Y-Intercept (Hong Kong) Ltd | $1981498 | 75572 | 0.08% | 股份 |
| JUPITER ASSET MANAGEMENT LTD | $1980685 | 75541 | 0.07% | 股份 |
| Erste Asset Management GmbH | $1956156 | 73100 | 0.07% | 股份 |
| FEDERATED HERMES, INC. | $1952315 | 74459 | 0.07% | 股份 |
| Jain Global LLC | $1917757 | 73141 | 0.07% | 股份 |
| Vontobel Holding Ltd. | $1789305 | 68242 | 0.07% | 股份 |
| MetLife Investment Management, LLC | $1747012 | 66629 | 0.07% | 股份 |
| Focus Partners Wealth | $1651363 | 62981 | 0.06% | 股份 |
| CenterBook Partners LP | $1597925 | 60943 | 0.06% | 股份 |
公司内部人士 18 位内幕人士 · 2 位高管 · 12 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Scott L Burrows | Chief Financial Officer | 2021年12月27日 S | 22679 | 0 | 0 | $0 |
| David W Osborne | Chief Technical Officer | 2020年2月4日 C | 270279 | 0 | 0 | $0 |
| Howard G. Welgus | 董事 | 2026年7月15日 M | 37109 | 0 | 3 | $-243567 |
| Christopher Peetz | 董事 | 2026年7月15日 A | 4315 | 0 | 0 | $0 |
| Sue-Jean Lin | 董事 | 2026年6月15日 S | 27567 | 0 | 1 | $-120583 |
| Neha Krishnamohan | 董事 | 2026年6月5日 A | 27901 | 0 | 0 | $0 |
| Terrie Curran | 董事 | 2026年6月5日 A | 23526 | 0 | 0 | $0 |
| Amit Munshi | 董事 | 2026年6月5日 A | 9799 | 0 | 0 | $0 |
| Halley E Gilbert | 董事 | 2026年6月5日 A | 27901 | 0 | 0 | $0 |
| Keith R Leonard | 董事 | 2026年6月5日 A | 27901 | 0 | 0 | $0 |
| Patrick J. Heron | 董事 | 2026年6月5日 A | 32213 | 0 | 0 | $0 |
| Jonathan Silverstein | 董事 | 2020年10月2日 P | 902286 | 0 | 0 | $0 |
| Bhaskar Chaudhuri | 董事 | 2020年2月4日 C | 49981 | 0 | 0 | $0 |
| Joseph L Turner | 董事 | 2020年1月30日 A | — | 0 | 0 | $0 |
| Patrick Burnett | — | 2026年8月12日 M | 119289 | 0 | 3 | $-419797 |
| Todd Franklin Watanabe | — | 2026年8月3日 S | 717203 | 0 | 1 | $-114275 |
| Masaru Matsuda | — | 2026年8月3日 S | 126171 | 0 | 1 | $-32128 |
| Ricky Sun | — | 2021年6月9日 A | — | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 3 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Frazier Life Sciences VIII, L.P., FHM LIFE SCIENCES VIII, L.P., FHM LIFE SCIENCES VIII, L.L.C., Frazier Life Sciences X, L.P., FHMLS X, L.P., FHMLS X, L.L.C., Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences Public Overage Fund, L.P., FHMLSP Overage, L.P., FHMLSP Overage, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., Frazier Life Sciences XII, L.P., FHMLS XII, L.P., FHMLS XII, L.L.C., James N. Topper, Patrick J. Heron ×8 申报 | 2025年8月20日 | 7.50% | 修订 | — | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP VII LLC, OrbiMed Capital LLC ×7 申报 | 2022年8月26日 | — | 初始申报 | — | SEC |
| Bain Capital Life Sciences Fund, L.P., BCIP Life Sciences Associates, LP ×4 申报 | 2022年8月8日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 45 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| PTH · Invesco Exchange-Traded Fund Trust | 1.38% | 134950 SH | 2026年8月8日 | 每日 |
| BBP · ETFis Series Trust I | 1.28% | 32610 NS | 2026年4月30日 | N-PORT |
| GURU · Global X Funds | 0.95% | 23918 NS | 2026年4月30日 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.88% | 196991 NS | 2026年4月30日 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0.54% | 70043 NS | 2026年5月31日 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trus... | 0.36% | 64844 SH | 2026年8月8日 | 每日 |
| FYC · First Trust Exchange-Traded Alpha... | 0.32% | 145888 NS | 2026年4月30日 | N-PORT |
| IBB · iShares Trust | 0.23% | 812141 SH | 2026年8月8日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.22% | 6809 SH | 2026年8月8日 | 每日 |
| AFSM · First Trust Exchange-Traded Fund ... | 0.20% | 9018 NS | 2026年5月31日 | N-PORT |
| IWO · iShares Trust | 0.19% | 1035865 SH | 2026年8月8日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.18% | 122691 SH | 2026年8月8日 | 每日 |
| OASC · Unified Series Trust | 0.17% | 6744 NS | 2026年5月31日 | N-PORT |
| FYX · First Trust Exchange-Traded Alpha... | 0.17% | 88401 NS | 2026年4月30日 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0.16% | 74441 NS | 2026年5月31日 | N-PORT |
| BIB · ProShares Trust | 0.13% | 4587 NS | 2026年5月31日 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund ... | 0.13% | 41766 NS | 2026年4月30日 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0.11% | 3711 NS | 2026年4月30日 | N-PORT |
| IWM · iShares Trust | 0.09% | 2886529 SH | 2026年8月8日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.09% | 658480 SH | 2026年8月8日 | 每日 |
| ISCG · iShares Trust | 0.09% | 33974 SH | 2026年8月8日 | 每日 |
| ESML · iShares Trust | 0.08% | 85491 SH | 2026年8月8日 | 每日 |
| RSSL · Global X Funds | 0.08% | 47709 NS | 2026年4月30日 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0.07% | 55080 SH | 2026年8月8日 | 每日 |
| FAD · First Trust Exchange-Traded Alpha... | 0.07% | 13604 NS | 2026年4月30日 | N-PORT |
| ITWO · ProShares Trust | 0.06% | 5179 NS | 2026年5月31日 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.05% | 534058 NS | 2026年5月31日 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Inde... | 0.05% | 5598 SH | 2026年8月8日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.05% | 51951 SH | 2026年8月8日 | 每日 |
| ISCB · iShares Trust | 0.04% | 4781 SH | 2026年8月8日 | 每日 |
| FHLC · FIDELITY COVINGTON TRUST | 0.04% | 50560 NS | 2026年4月30日 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.04% | 335913 SH | 2026年8月8日 | 每日 |
| UWM · ProShares Trust | 0.03% | 4051 NS | 2026年5月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.03% | 1307970 SH | 2026年8月8日 | 每日 |
| URTY · ProShares Trust | 0.03% | 4104 NS | 2026年5月31日 | N-PORT |
| WSML · iShares Trust | 0.02% | 6296 SH | 2026年8月8日 | 每日 |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.01% | 4427 NS | 2026年5月31日 | N-PORT |
| HDG · ProShares Trust | 0.01% | 103 NS | 2026年5月31日 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0.01% | 33557 NS | 2026年5月31日 | N-PORT |
| ITOT · iShares Trust | 0.00% | 152941 SH | 2026年8月8日 | 每日 |
| IWV · iShares Trust | 0.00% | 31312 SH | 2026年8月8日 | 每日 |
| TILT · FlexShares Trust | 0.00% | 3054 NS | 2026年4月30日 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 64126 NS | 2026年5月31日 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 3565928 SH | 2026年8月8日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 9521 SH | 2026年8月8日 | 每日 |